Or Unresectable Solid Tumor Malignancy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2015-01-14
Clinical Trial Update: A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating AUY922 (an Hsp90 inhibitor) in combination with capecitabine for metastatic or unresectable solid tumors has comple…